CDK9 is a potential target as it is part of P-TEFb, is necessary for proliferation and maintenance of MYC-overexpressing hepatocellular carcinoma [53], and is required for maintenance of gene silencing in several cancer cell lines [54]. Here, CDK9 is linked to cancer.